Metagenomi Therapeutics, Inc. (MGX) Total liabilities 2023–2025
Metagenomi Therapeutics, Inc. (MGX) total liabilities at each fiscal year-end, per SEC filings.
$62.5MFY2025 · since FY2023: $149.7M → $62.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $62.5M | -30.3% |
| FY2024 | $89.7M | -40.0% |
| FY2023 | $149.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice